Your browser doesn't support javascript.
loading
Neoalbaconol inhibits cell growth of human cholangiocarcinoma cells by up-regulating PTEN.
Zhou, Guang-Yao; Pan, Chen-Wei; Jin, Ling-Xiang; Zheng, Jian-Jian; Yi, Yong-Xiang.
Afiliación
  • Zhou GY; Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University Wenzhou 325027, China.
  • Pan CW; Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University Wenzhou 325027, China.
  • Jin LX; Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University Wenzhou 325027, China.
  • Zheng JJ; Wenzhou Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, China.
  • Yi YX; Department of Hepatobiliary Surgery, The Second Hospital of Nanjing, Affiliated to Southeast University Nanjing 210003, China.
Am J Transl Res ; 8(2): 496-505, 2016.
Article en En | MEDLINE | ID: mdl-27158342
ABSTRACT
The recently isolated small-molecule neoalbaconol (NA) from Albatrellus confluens has been suggested to possess the ability to inhibit cell growth of many cancer cells. In this study, we investigated the role of NA in the regulation of cell apoptosis in human cholangiocarcinoma cell lines both in vitro and in vivo. Our results indicate that NA could induce cancer cell death via the AKT pathway by targeting phosphorate and tension homolog detected on chromosome 10 (PTEN) and supported the feasibility of NA being a novel chemotherapeutic treatment for human cholangiocarcinoma.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Transl Res Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Transl Res Año: 2016 Tipo del documento: Article País de afiliación: China
...